APA aipamena

Bradbury, L., Barlow, S., Geoghegan, F., Hannon, R., Stuckey, S., Wass, J., . . . Duncan, E. (2012). Risedronate in adults with osteogenesis imperfecta type I: Increased bone mineral density and decreased bone turnover, but high fracture rate persists.

Chicago Style aipamena

Bradbury, L., S. Barlow, F. Geoghegan, R. Hannon, S. Stuckey, J. Wass, R. Russell, M. Brown, and E. Duncan. Risedronate in Adults with Osteogenesis Imperfecta Type I: Increased Bone Mineral Density and Decreased Bone Turnover, but High Fracture Rate Persists. 2012.

MLA aipamena

Bradbury, L., et al. Risedronate in Adults with Osteogenesis Imperfecta Type I: Increased Bone Mineral Density and Decreased Bone Turnover, but High Fracture Rate Persists. 2012.